Harvard Medical School-Massachusetts General Hospital is a clinical research site located in Boston, Massachusetts, United States 02114.
Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.
Harvard Medical School-Massachusetts General Hospital has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer), Heart Failure With Preserved Ejection Fraction.
Sponsors: Acerand Therapeutics (Hong Kong) Limited, Salubris Biotherapeutics Inc, Northwell Health.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Boston
Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Harvard Medical School-Massachusetts General Hospital has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Harvard Medical School-Massachusetts General Hospital has 8 clinical trials on record, with 2 currently active. Their work covers Prostate Cancer (Adenocarcinoma), mCRPC (Metastatic Castration-resistant Prostate Cancer), Heart Failure With Preserved Ejection Fraction.
Harvard Medical School-Massachusetts General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.